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To examine the possibility that staurosporine is applic-
able for the treatment of abnormal scar formation such
as hypertrophic scar and keloid, the cellular process
during staurosporine-induced apoptosis was analyzed
in myo¢broblasts isolated from a rat granulation tissue
pouch. Staurosporine induced myo¢broblast apoptosis
in a time- and dose-dependent manner with typical
morphologic changes. Staurosporine (1 lM) activated
caspase-3 up to 3.6-fold by cleaving pro-caspase-3
(32 kDa) to active forms (17, 19, and 20 kDa). Micro¢la-
ments mainly composed of a-smooth muscle actin, a
contractile protein characterizing myo¢broblasts, were
degraded during staurosporine-induced apoptosis. The
degradation of a-smooth muscle actin bundles was
detected as early as 1 h after the treatment with
staurosporine. Recombinant active caspase-3 and
staurosporine-stimulated caspase-3 both cleaved puri-
¢ed a-smooth muscle actin in vitro. These results sug-
gested that a-smooth muscle actin is directly degraded
by caspase-3 in response to apoptotic stimuli in myo¢-
broblasts. In addition, bleomycin (100 ng per ml)
and cisplatin (1 mM) also induced myo¢broblast
apoptosis by activating caspase-3, suggesting that
these agents have a potential therapeutic value for ab-
normal scar formation. Key words: Caspase-3/wound heal-
ing/cytoskeleton. J Invest Dermatol 119:1008 ^1013, 2002
T
issue contraction that occurs in wound healing is an
important process for wound closure. In this process,
myo¢broblasts, which have di¡erentiated from
¢broblasts and acquired strong contractility, play a
major role. Fibroblasts proliferate and/or migrate to
the site of injury and then di¡erentiate to myo¢broblasts charac-
terized by the appearance of cytoplasmic micro¢laments mainly
composed of a-smooth muscle actin (a-SM actin) (Darby et al,
1990). a-SM actin is an actin isoform typical of smooth muscle
cells, which endows myo¢broblasts with strong contractility
(Hinz et al, 2002). Once a wound has been closed, however,
myo¢broblasts may no longer be required. Darby et al (1990)
showed that myo¢broblasts disappear from the experimental
wound probably due to apoptosis when the scar develops.
Further, Desmouliere et al (1995) demonstrated that apoptosis is
the mechanism through which myo¢broblasts disappear during
the transition between granulation tissue and scar formation.
They implied that hypertrophic scars or keloids may be the con-
sequence of a lack of myo¢broblast apoptosis at an appropriate
time of healing. Therefore, to understand the physiology of
wound healing and to develop a new therapeutic strategy for ab-
normal scar formation such as hypertrophic scars and keloids it is
important to determine the mechanism of myo¢broblast apopto-
sis. The biologic mechanism of myo¢broblast apoptosis during
the wound healing process is not yet clear, however.
During apoptosis, cells undergo characteristic morphologic
changes: cell shrinkage, nuclear shrinkage, chromatin conden-
sation, and formation of apoptotic bodies (Kerr et al, 1972; Ra¡,
1992). These changes require a marked reorganization of the
cytoskeleton (Yamazaki et al, 2000; Paddenberg et al, 2001).
Micro¢laments have been suggested to be involved in morpholo-
gic changes of apoptosis, and indeed the cleavage of cytoskeletal
proteins, including actin, by caspases was found in apoptotic cells
(Chan and Mattson, 1999; Mashima et al, 1999).
In this study, the e¡ect of staurosporine (STS), which is known
to induce apoptosis in a number of mammalian cell species
( Jacobson et al, 1994), on myo¢broblasts isolated from a rat
granulation tissue pouch was analyzed to help clarify the mechan-
isms of myo¢broblast apoptosis and to investigate the
possibility that STS or its analogs are applicable to abnormal scar
formation.
MATERIALS ANDMETHODS
Cell culture Myo¢broblasts were isolated from a granulation tissue
pouch in the rat dorsal subcutaneous tissue as described previously (Goto
et al, 1998). Brie£y, the granulation tissue pouch was created in maleWister
rats (120^150 g) by the injection of 30ml of air into the dorsal
subcutaneous tissue followed by 1ml of 0.1% croton-oil dissolved in
maize oil (Appleton et al, 1992). After 23^26 d, the pouch was dissected
and digested using 2000 U per ml dispase (Godo-Shusei, Japan) at 371C
for 1 h with gentle stirring. The myo¢broblasts obtained were maintained
in Dulbecco’ modi¢ed Eagle’ medium (Sigma, St. Louis, MO) supple-
mented with 10% fetal bovine serum (FBS), 100 U per ml penicillin G
(Meiji-Seika, Japan), and 100 mg per ml streptomycin (Meiji-Seika). Cells
in passages 2^8 were used for all experiments. To isolate and culture
normal ¢broblasts, connective tissue was dissected from the dorsal
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subcutaneous region of normal Wister rats and treated in the same way as
described above.
Induction of apoptosis Myo¢broblasts were plated on plastic tissue
culture dishes or collagen-coated coverslips. After 24 h incubation, cells
were treated with STS (0^1000 nM, Wako, Japan), cisplatin (1 mM,
Sigma), bleomycin (100 ng per ml, Wako), anti-Fas monoclonal antibody
(clone CH-11, 500 ng per ml, MBL, Japan), tumor necrosis factor a
(TNF-a) (50 ng per ml, Genzyme TECHNE, Minneapolis, MN),
interferon-g (IFN-g) (1000 U per ml, Genzyme TECHNE), transforming
growth factor b1 (TGF-b) (100 ng per ml, King Brewing, Japan), platelet-
derived growth factor BB (PDGF-BB) (100 ng per ml, PeproTech, U.K.), or
endothelin-1 (1 mM, Peptide Institute, Japan) for the indicated periods.
Flow cytometry analysis Apoptotic cells were quanti¢ed using £ow
cytometry. Myo¢broblasts were incubated with or without stimulants
for the indicated periods and then harvested by trypsin/ethylenediamine
tetraacetic acid (Gibco BRL) treatment. The cells were stained with
annexin V-£uorescein isothiocyanate (FITC) and propidium iodide (PI)
using a MEBCYTO Apoptosis Kit (MBL). Cells 1104 for each sample
were analyzed with a Becton-Dickinson FACScalibur (Franklin Lakes, NJ).
Fluorescence staining Myo¢broblasts plated on collagen-coated
coverslips were washed with phosphate-bu¡ered saline. For the assessment
of nuclear morphology, cells were stained with 1 mM of Hoechst 33342 dye
(Molecular Probes, Eugene, OR) and observed using £uorescence micro-
scopy (Olympus, Japan). Immunostaining of a-SM actin was performed as
described previously with slight modi¢cations (Goto et al, 1998). Brie£y,
cells were ¢xed with 4% paraformaldehyde and permeabilized with 0.2%
(vol/vol) Triton-X 100 in phosphate-bu¡ered saline (Sigma). After
blocking with 5% skimmed milk for 30 min, ¢xed cells on coverslips
were probed with a mouse monoclonal anti-a-SM actin antibody (1:100
dilution, Progen, Germany) for 1 h at room temperature followed by
incubation with rabbit antimouse IgGþ IgAþ IgM-biotin (Nichirei,
Japan) for 30 min at room temperature. Cells were then incubated with
streptavidin-FITC conjugate (1:50 dilution, Gibco BRL) for 30 min and
washed with phosphate-bu¡ered saline. The cells were observed with
£uorescence microscopy.
Immunoblotting Samples were separated by 12% (for a-SM actin, all
actin isoforms, b-actin) or 15% (for caspase-3) sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a
polyvinylidene di£uoride membrane using a semidry transfer system (1 h,
15 V). After blocking with 5% skimmed milk for 30 min, the membrane
was probed with a monoclonal anti-a-SM actin antibody, a monoclonal
antibody to all actin isoforms (clone C4, Chemicon, Temecula, CA), a
monoclonal anti-b-actin antibody (clone AC-74, Sigma), or a polyclonal
anticaspase-3 antibody (Upstate Biotechnology, Lake Placid, NY) for 1 h
at room temperature. The membrane was washed three times and
incubated with horseradish-peroxidase-conjugated antimouse IgG
or horseradish-peroxidase-conjugated goat antirabbit IgG (Bio-Rad,
Hercules, CA) for 30 min. Immunoreactive proteins were then visualized
by treatment with a detection reagent (Super Signal West Dura, Pierce,
Rockford, IL). An optical densitometric scan was performed using
Science Lab99 Image Gauge Software (Fujiphoto Film, Japan).
Caspase-3 activity assay Myo¢broblasts (1106 cells) were incubated
with or without stimulants for the indicated periods and lysed on ice for
10min. The cell lysate (100 ml) was incubated with 200 mM DEVD-p-
nitroanilide (CPP/Caspase-3 colorimetric protease assay kit, MBL) at
371C for 3 h. Fluorescence of the samples was measured at 405 nm to
determine the caspase-3 activity.
Puri¢cation of a-SM actin a-SM actin was puri¢ed from an acetone-
dried powder of freshly isolated bovine aorta according to the procedure of
Spudich and Watt (1971). The acetone-dried powder (1 g) was extracted
with 20 ml of bu¡er A (2 mM Tris-HCl pH 8.0, 0.2 mM CaCl2, 0.5 mM
b-mercaptoethanol, and 0.2 mM ATP) for 30min at 01C and ¢ltered
through a coarse sintered glass funnel. The residue was washed with
100ml of bu¡er A. The £ow through was centrifuged at 10,000 g for 1 h
at 21C. Three molar KCl solution was added to the supernatant to give a
¢nal concentration of 50 mM and the actin was allowed to polymerize for
2 h at 251C. Three molar KCl solution was then added to give a ¢nal
concentration of 0.6 M and the sample was stirred gently for 1.5 h at
room temperature. The solution was centrifuged at 80,000 g for 3 h at
251C and the pellet was resuspended with 3 ml of bu¡er A. The sample
was dialyzed against bu¡er A with vigorous stirring for 3 d changing the
bu¡er every 24 h.The G-actin was obtained by centrifugation at 80,000 g
for 3 h at 21C and polymerized in 50 mM KCl.
Immunoprecipitation of caspase-3 Myo¢broblasts were incubated
with or without STS and washed with phosphate-bu¡ered saline. Cells
were lysed on ice for 10 min and insoluble cell debris was removed
by centrifugation at 5000 rpm for 3 min. The cell lysate was precleared
with protein A-sepharose CL-4B (Sigma) and then incubated with an
anticaspase-3 antibody (4.5 mg) and protein A-sepharose CL-4B (5 mg) at
41C for 2 h in 1ml of the ICE assay bu¡er [20 mM HEPES pH 7.5, 2 mM
dithiothreitol, 10% (vol/vol) glycerol] Mashima et al, 1997) supplemented
with 1 mM phenylmethylsulfonyl £uoride, 1 mg per ml leupeptin, and 1
mg per ml pepstatin. After incubation, the protein bound with the
antibody/protein A-sepharose complex was precipitated by centrifugation
at 15,000 rpm for 5 min and washed three times with the ICE assay
bu¡er. The immunoprecipitated caspase-3 was used for the a-SM actin
cleavage assay.
a-SM actin cleavage assay in vitro Bovine aortic smooth muscle actin
was labeled with biotin-(AC5)2 Sulfo-Osu (Biotinylation Kit, Dojindo
Laboratory, Japan). The biotinylated actin (0.4 mg) was incubated with
immunoprecipitated caspase-3 or 12 units of human recombinant active
caspase-3/CPP32 (MBL) for 2 h at 371C in 50 ml of ICE assay bu¡er.
The samples were separated by 15% SDS-PAGE and transferred to a
polyvinylidene di£uoride membrane. After blocking with 5% skimmed
milk for 30 min, the membrane was incubated with horseradish-
peroxidase-conjugated avidin (Bio-Rad) for 1 h at room temperature. The
membrane was washed three times and treated with detection reagent
(Super SignalWest Dura).
RESULTS
Characterization of the cells isolated from the granulation
tissue pouch Myo¢broblasts are distinguished from ¢bro-
blasts by the expression of a-SM actin, a contractile protein
that provides myo¢broblasts with strong contractility (Serini
and Gabbiani, 1999). We performed immunostaining
and immunoblotting for a-SM actin to con¢rm that the
cultured cells isolated from the granulation tissue pouch were
myo¢broblasts. As shown in Fig 1(A), the majority of the cells
exhibited prominent bundles of a-SM actin, running parallel to
the longitudinal axis of the cells. We previously reported that
approximately 90% of the cells obtained from the granulation
tissue pouch showed prominent bundles of a-SM actin (Goto
et al, 1998). A Western blot analysis showed that both the
granulation tissue pouch and the cultured cells from the pouch
were rich in a-SM actin, whereas the ¢broblasts from the
normal dorsal subcutaneous tissue did not express a-SM actin
(Fig 1B). These results indicated that the cultured cells isolated
from the granulation tissue pouch were mainly myo¢broblasts.
Induction of myo¢broblast apoptosis by STS To examine
whether STS induces apoptosis in myo¢broblasts, we performed
£ow cytometric analysis. Cells undergoing apoptosis expose
phosphatidylserine on the outer surface membrane and are
detected by annexin V binding (Walsh et al, 1998; Van Heerde
et al, 2000). Cells undergoing secondary necrosis, however, are
not only positive in annexin V binding but also stain with PI.
We counted cells stained with FITC-labeled annexin V as
apoptotic cells. As shown in Fig 2(A), (B), apoptotic cells were
signi¢cantly increased by STS treatment in a time- and a dose-
dependent manner. Treatment with 10 nM of STS for 24 h
induced apoptosis in approximately 50% of the cells, and the
maximal e¡ect was obtained at 1 mM. Hoechst 33342 dye
staining of the STS-treated cells showed nuclear shrinkage
and chromatin condensation, morphologic changes typical of
apoptotic cells (Fig 2C). These ¢ndings suggested that STS
rapidly and strongly induced apoptosis in myo¢broblasts.
Activation of caspase-3 in STS-induced apoptosis As
caspase-3 is a key protease in the apoptosis signal transduction,
whether STS activates caspase-3 was examined by Western
blotting. Caspase-3 is usually present as a 32-kDa pro-form
(pro-caspase-3). In response to proapoptotic signals, pro-caspase-
3 is cleaved at 175Asp followed by further cleavage at 9Asp and
28Asp, resulting in the production of the E20 kDa (p20),
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E19 kDa (p19), E17 kDa (p17), andE12 kDa (p12) active forms
of this enzyme (Fernandes-Alnemri et al, 1996). Treatment with
STS decreased the amount of pro-caspase-3 and increased the
active forms of caspase-3. The active forms of caspase-3 were
increased at 3 h treatment with STS and reached maximal levels
at 6 h (Fig 3A). To measure the activity of caspase-3, lysates from
STS-treated myo¢broblasts were assayed for caspase-3 activity
using DEVD-p-nitroanilide as the substrate. The lysates from
STS-treated myo¢broblasts showed a greater than 3.6-fold
increase in caspase-3 activity at 6 h treatment compared with the
control and the activity declined to the baseline at 24 h (Fig 3B),
consistent with the result shown in Fig 3(A). These results
suggested that caspase-3 was activated by STS at an early stage
of myo¢broblast apoptosis.
Degradation of a-SM actin in STS-induced apoptosis The
progressive changes of a-SM actin were observed in STS-treated
myo¢broblasts using immuno£uorescence detection.The bundles
of stress ¢bers composed of a-SM actin were already indistinct
after 1 h treatment with STS and were condensed in the
periphery of the cells due to destruction after 6 h treatment
(Fig 4A). We then carried out Western blotting to analyze the
changes in the amount of a-SM actin in myo¢broblasts after
STS treatment. As shown in Fig 4(B), (C), the amount of a-SM
actin was decreased as early as 1 h after the treatment with STS
(64.0%718.9% of control; mean7SEM, n¼ 3).We also used an
antibody speci¢c to b-actin and an antibody recognizing all actin
isoforms (six known isoforms of actin including four muscle
actins and two cytoplasmic actins) to investigate whether STS
selectively degrades a-SM actin. Both the level of b-actin and
the total amount of all the actin isoforms, however, were not
signi¢cantly changed even after 6 h treatment (80.5%710.6%
and 95.4%78.4% of control, respectively; mean7SEM, n¼ 3).
These results suggested that a-SM actin was selectively degraded
Figure1. Characterization of the cells isolated and cultured from
the granulation tissue pouch. (A) Immuno£uorescence staining with
anti-a-SM actin antibody. Cells were plated and grown on collagen-coated
coverslips and ¢xed with 4% paraformaldehyde. Samples were probed
with anti-a-SM actin antibody. Scale bar: 10 mm. (B) Western blot analysis
with anti-a-SM actin antibody. Samples were separated by 12% SDS-
PAGE and immunoblot analysis was carried out using anti-a-SM actin
antibody. Lane 1, granulation tissue pouch; lane 2, cultured cells from the
granulation tissue pouch; lane 3, cultured ¢broblasts.
Figure 2. Myo¢broblast apoptosis induced by STS. (A) Time course.
Cells were treated with (closed circle) or without (open circle) 1 mM STS for
the indicated periods (0, 6, 12, 24 h) and stained with annexinV/FITC and
PI for £ow cytometry analysis. Values are means 7 SEM of six indepen-
dent experiments. nnpo0.01 compared with at time 0 (Student’ t test). (B)
Dose dependence. Cells were treated with STS (0^1000 nM) for 24 h and
stained with annexinV/FITC and PI for £ow cytometry analysis.Values are
means 7 SEM of six independent experiments. nnpo0.01 compared with
at time 0 (Student’ t test). (C) Nuclear staining with Hoechst 33342 dye.
Cells were plated and grown on collagen-coated coverslips with or with-
out 1 mM STS for 3 h and stained with Hoechst 33342 dye. The results
shown are representative of four independent experiments. Scale bar: 10 mm.
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in an early stage of the STS-induced apoptosis, in accordance
with the time course of caspase-3 activation.
Cleavage of puri¢ed a-SM actin by caspase-3 in vitro Actin
is cleaved by activated caspase-3 in several types of cells (Chan
and Mattson, 1999). To clarify whether a-SM actin in myo-
¢broblasts is also cleaved by caspase-3, a-SM actin puri¢ed from
bovine aortic media was biotinylated and incubated with caspase-
3 in vitro. We con¢rmed that the puri¢ed protein was a-SM
actin using anti-a-SM actin antibody (data not shown). As
shown in Fig 5(A), recombinant active caspase-3 cleaved a-SM
actin to E30 and E15 kDa fragments. We further investigated
whether caspase-3 in STS-treated myo¢broblasts also cleaves
a-SM actin in vitro. Caspase-3 was immunoprecipitated from myo-
¢broblasts treated with 1 mM of STS for 6 h and incubated with
biotinylated a-SM actin. Fig 5(B) shows that the immuno-
precipitated caspase-3 cleaved a-SM actin to E30 kDa
fragments. These results suggested that a-SM actin is the
substrate for caspase-3 activated in the process of STS-induced
apoptosis in myo¢broblasts.
Agents inducing myo¢broblast apoptosis Little is known
about the physiologic stimuli leading to myo¢broblast apoptosis.
It has been reported that serum withdrawal, irradiation, and loss
of adhesion to extracellular matrix could not induce apoptosis in
cultured primary myo¢broblasts (McKenna et al, 1996; McGill
et al, 1997). We investigated whether cytokines and growth
factors, known to be involved in wound healing (Serini and
Gabbiani, 1999), induce myo¢broblast apoptosis. Myo¢broblasts
treated with stimuli for 48 h in serum-free medium were
Figure 3. E¡ect of STS on caspase-3 in myo¢broblasts. (A) Western
blot analysis of casapase-3. Cells were treated with 1 mM STS for the indi-
cated periods (0, 1, 3, 6, 12, 24 h). Samples were separated by 15% SDS-
PAGE and immunoblot analysis was carried out using anticaspase-3 anti-
body. Results are representative of three independent experiments. (B)
Time course of caspase-3 activity induced by STS. Cells were treated with
(closed circle) or without (open circle) 1 mM STS for the indicated periods (0, 3,
6, 12, 24 h). Cell lysate was incubated with DEVD-p-nitroanilide at 371C
for 3 h and the samples were measured at 405 nm. Values are means 7
SEM of three independent experiments. nnpo 0.01 compared with at time
0 (Student’ t test).
Figure 4. a-SM actin degradation induced by STS in myo¢bro-
blasts. (A) Time course of immuno£uorescence staining with anti-a-SM
actin antibody. Cells were plated and grown on collagen-coated coverslips.
After 24 h incubation, cells were treated with 1 mM STS for the indicated
periods (0, 1, 6, 24 h) and ¢xed with 4% paraformaldehyde. Samples were
probed with anti-a-SM actin antibody. The results are representative of
three independent experiments. Scale bar: 20 mm. (B) Western blot analysis
with anti-a-SM actin antibody. Cells were treated with 1 mM STS for the
indicated periods (0, 1, 3, 6, 12, 24 h). Samples were separated by 12% SDS-
PAGE and immunoblot analysis was performed using anti-a-SM actin
antibody. The results are representative of three independent experiments.
(C) Quanti¢cation of a-SM actin.The levels of a-SM actin were quanti¢ed
and shown as a percentage of the levels of a-SM actin in control (time 0)
cells.Values are means7 SEM of three independent experiments. nnpo0.01
compared with at time 0 (Student’ t test).
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analyzed by £ow cytometry. As shown in Fig 6(A), anti-Fas
antibody (100 ng per ml), TNF-a (50 ng per ml), TGF-b1
(100 ng per ml), and endothelin-1 (1 mM) did not induce
apoptosis even in the absence of serum. IFN-g (1000 U per ml)
and PDGF-BB (100 ng per ml) instead suppressed apoptosis. On
the other hand, the synthetic chemical compounds bleomycin
(100 ng per ml) and cisplatin (1 mM) induced apoptosis and
activated caspase-3, although the e¡ects of these compounds
were much slower than STS (Fig 6A, B).
DISCUSSION
In this study, we showed that myo¢broblasts undergo apoptosis
by the treatment with STS, with typical morphologic changes
such as nuclear shrinkage, chromatin condensation, and cell
shrinkage. Mechanisms that cause these cell shape changes may
involve the breakdown of cytoskeleton. In an attempt to address
the relation between changes in cell morphology and those in
cytoskeletal organization during apoptosis, we found that stress
¢bers mainly composed of a-SM actin were disrupted, accompa-
nied by the degradation of a-SM actin at an early stage of
STS-induced apoptosis. As b-cytoplasmic actin is also highly ex-
pressed in myo¢broblasts as well as a-SM actin (Hinz et al, 2002),
we examined the e¡ects of STS on the amount of b-actin and the
total amount of all actin isoforms. Their degradation was not sig-
ni¢cant at 6 h after the treatment with STS, however. Therefore,
the proteolysis of a-SM actin may selectively occur in an early
stage of the STS-induced apoptosis in myo¢broblasts.
Caspases have been reported to cleave actin in several types of
cells (Chan and Mattson, 1999). Actin is mainly cleaved at 244Asp
producing E30 and E15 kDa fragments (Kayalar et al, 1996;
Mashima et al, 1997). Amino acid sequences in actin isoforms are
very well conserved and exhibit only small di¡erences (less than
7%), which may relate to functional di¡erences (Serini and
Gabbiani, 1999). As a-SM actin also has a cleavage site for cas-
pase-3 (at 246Asp in humans and rats and at 244Asp in bovine)
(Vandekerckhove and Weber, 1979; McHugh and Lessard, 1988;
Kamada and Kakunaga, 1989), we tried to clarify whether cas-
pase-3 is also able to degrade a-SM actin. The anti-a-SM actin
antibody used was expected to recognize E30 kDa fragments;
however, we failed to detect the cleavage products in our experi-
mental system.We do not know the precise reason for this failure,
but the amount of cleaved endogenous a-SM actin appeared to
be too small to be detected by this antibody. Therefore, we em-
ployed biotinylated a-SM actin for this analysis. As demon-
strated, a-SM actin, puri¢ed from bovine aorta and biotinylated,
was cleaved not only by recombinant active caspase-3 but also
by native caspase-3 immunoprecipitated from STS-treated
myo¢broblasts.
At this stage, however, the role of a-SM actin cleavage in myo-
¢broblast apoptosis is not clear. Further investigation is required
to clarify this point. It is possible, however, that a-SM actin clea-
vage during myo¢broblast apoptosis may be required for the
disappearance of granulation tissue, resulting in normal scar
Figure 5. Cleavage of puri¢ed a-SM actin by activated caspase-3.
(A) Recombinant human active caspase-3. Biotinylated a-SM actin was in-
cubated with or without recombinant active caspase-3 for 2 h at 371C. Lane
1, biotinylated a-SM actin alone; lane 2, biotinylated a-SM actin + recom-
binant active caspase-3. (B) Immunoprecipitated caspase-3. Biotinylated a-
SM actin was incubated with immunoprecipitated caspase-3 from cells
treated with or without STS for 6 h. Lane 1, biotinylated a-SM actin +
recombinant active caspase-3; lane 2, biotinylated a-SM actin + immuno-
precipitated caspase-3 from nontreated cells; lane 3, biotinylated a-SM actin
+ immunoprecipitated caspase-3 from STS-treated cells. Samples were se-
parated by 15% SDS-PAGE and the cleavage of a-SM actin was detected
with peroxidase-conjugated avidin.Values are representative of three inde-
pendent experiments.
Figure 6. Agents inducing myo¢broblast apoptosis. (A) Flow cytometry
analysis of myo¢broblasts exposed to the stimulants. Cells were treated
with STS (1 mM), bleomycin (100 ng per ml), cisplatin (1 mM), anti-Fas
monoclonal antibody (500 ng per ml), TNF-a (50 ng per ml), TGF-b1
(100 ng per ml), endothelin-1 (1 mM), IFN-g (1000 U per ml), or PDGF-
BB (100 ng per ml) for 48 h in the absence of FBS. Values are means 7
SEM of three independent experiments. nnp o 0.01 compared with con-
trol (without 10% FBS) (Student’ t test). (B) Time course of the caspase-3
activity. Cells were treated with bleomycin (100 ng per ml), cisplatin (1
mM), and STS (1 mM) for the indicated periods (0, 6, 12, 24, 48 h) in the
absence of FBS. The cells were lysed on ice and the cell lysate was incu-
bated with DEVD-p-nitroanilide at 371C for 3 h. Samples were measured
at 405 nm.Values are means7 SEM of three independent experiments:J,
control; , STS; &, bleomycin;W, cisplatin. np o 0.05, nnp o 0.01 com-
pared with control (without 10% FBS) (Student’ t test).
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formation, and that disorder in this process might lead to the de-
velopment of abnormal scar formation such as hypertrophic scar
and keloid formation.
STS, originally isolated from Streptomyces as a potential anti-
fungal agent, is known to be a potent inhibitor of protein kinase
C. In this study, we showed that STS induced apoptosis through
the activation of caspase-3 in myo¢broblasts. Some studies have
suggested that STS induces cellular apoptosis through the inhibi-
tion of protein kinase C (Jarvis et al, 1994; Ferraris et al, 1997). Re-
cently, however, it was reported that STS-induced apoptosis is
protein kinase C independent (Han et al, 2000).Whatever the in-
volvement of protein kinase C, STS induces a release of cyto-
chrome c from mitochondria to activate downstream caspase-3,
resulting in apoptotic cell death (Desagher et al, 1999).
Not only STS but bleomycin and cisplatin also induced myo-
¢broblast apoptosis by activating caspase-3. Therefore, all of these
compounds might have therapeutic value for abnormal scar
formation. Indeed, intradermal bleomycin injection has been
reported to be e¡ective for the treatment of keloid and hyper-
trophic scars (Espana et al, 2001). As STS induced apoptosis faster
than the compounds we tested in this study, STS or its analogs
might be more e¡ective for these disorders than bleomycin and
cisplatin. Indeed, the STS analog, N-benzoylated staurosporine,
has been tested as an orally administrable anticancer agent in a
phase I clinical trial (Propper et al, 2001). It is possible that this
agent is clinically applicable to abnormal scar formation such as
hypertrophic scar and keloid formation.
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